Research Topics
| Jennifer A LigibelSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
|
Detail Information
Publications
Lifestyle factors in cancer survivorshipJennifer Ligibel
Dana Farber Cancer Institute, Boston, MA 02215, USA
J Clin Oncol 30:3697-704. 2012..This article reviews the evidence that links lifestyle factors to cancer outcomes, provides clinical recommendations for cancer survivors, and describes future directions for lifestyle research in cancer survivors...
Patterns of bone density evaluation in a community population treated with aromatase inhibitorsJennifer A Ligibel
Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
Breast Cancer Res Treat 134:1305-13. 2012..Attention is needed to insure that unnecessary fractures are avoided in breast cancer patients taking AIs...- Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group settingJennifer A Ligibel
Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
Breast Cancer Res Treat 132:205-13. 2012..Lifestyle intervention research is feasible in a cooperative group setting... 
Obesity and breast cancerJennifer Ligibel
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
Oncology (Williston Park) 25:994-1000. 2011....- Role of adjuvant and posttreatment exercise programs in breast healthJennifer A Ligibel
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
J Natl Compr Canc Netw 9:251-6. 2011..This article reviews the growing evidence that exercise could be an important part of breast cancer survivorship, and describes current exercise guidelines for breast cancer survivors... - Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancerJennifer A Ligibel
Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
J Womens Health (Larchmt) 19:1553-9. 2010..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients... - Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivorsJennifer A Ligibel
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
Cancer Causes Control 20:1523-8. 2009..This study examines the impact of exercise upon levels of adiponectin, high molecular weight adiponectin (HMWA), and leptin in breast cancer survivors... - Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situJennifer A Ligibel
Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
Ann Surg Oncol 16:106-12. 2009..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity... - Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivorsJennifer A Ligibel
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
J Clin Oncol 26:907-12. 2008..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors... - Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questionsJennifer A Ligibel
Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
Breast Cancer Res 7:255-7. 2005..Ongoing trials will compare these approaches and guide the use of these agents in the years to come... - Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patientsJennifer A Ligibel
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Breast Cancer Res Treat 131:589-97. 2012..The side effect profile of AIs in this community-based population was similar to that seen in clinical trials. These findings provide reassurance that AIs appear to be associated with few serious side effects... - A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastasesRachel A Freedman
Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
Clin Breast Cancer 11:376-83. 2011..We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS was disappointing. Further studies should focus on other agents to treat this challenging clinical problem... - Clinical differences among the aromatase inhibitorsJennifer A Ligibel
Harvard Medical School, Women's Hospital, Boston, Massachusetts 02115, USA
Clin Cancer Res 9:473S-9S. 2003..This article explores the efficacy and tolerability of the aromatase inhibitors in both the metastatic and the adjuvant settings... - Mucinous breast carcinoma: a large contemporary seriesChristina R Barkley
Department of Surgery, Brigham and Women s Hospital, Boston, MA, USA
Am J Surg 196:549-51. 2008..Mucinous breast cancer is typically associated with a favorable prognosis. This study aimed to assess recent trends and prognostic features in the treatment of mucinous breast carcinoma... - Trastuzumab/chemotherapy combinations in metastatic breast cancerJennifer A Ligibel
Harvard Medical School, Boston, MA 02115, USA
Semin Oncol 29:38-43. 2002....